Mining Academic Publications to Predict Automation

This paper proposes a novel framework of predicting future technological change. Using abstracts of academic publications available in the Microsoft Academic graph, co-occurrence matrices are generated to indicate how often occupation and technological terms are referenced together. This matrices are used in linear regression models to predict future co-occurrence of occupations and technologies with a relatively high degree of accuracy as measured through the mean squared error of the models. While this work is unable to link the co-occurrences found in academic publications to automation in the labor force due to a dearth of automation data, future work conducted when such data is available could apply a similar approach with the aim of predicting automation from trends in academic research and publications

The James Webb Space Telescope Mission

Twenty-six years ago a small committee report, building on earlier studies, expounded a compelling and poetic vision for the future of astronomy, calling for an infrared-optimized space telescope with an aperture of at least $4m$. With the support of their governments in the US, Europe, and Canada, 20,000 people realized that vision as the $6.5m$ James Webb Space Telescope. A generation of astronomers will celebrate their accomplishments for the life of the mission, potentially as long as 20 years, and beyond. This report and the scientific discoveries that follow are extended thank-you notes to the 20,000 team members. The telescope is working perfectly, with much better image quality than expected. In this and accompanying papers, we give a brief history, describe the observatory, outline its objectives and current observing program, and discuss the inventions and people who made it possible. We cite detailed reports on the design and the measured performance on orbit.Comment: Accepted by PASP for the special issue on The James Webb Space Telescope Overview, 29 pages, 4 figure

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination - Fig 3

<p>Mean peak neutralizing antibody titers (PRNT₅₀) for DENV-1(<b>A</b>), DENV-2 (<b>B</b>), DENV-3 (<b>C</b>), and DENV-4 (<b>D)</b> up to 90 days following one dose of TV003 in flavivirus-naïve subjects (n = 58, from ref. [<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005584#pntd.0005584.ref019" target="_blank">19</a>]), all flavivirus-experienced (all FV+) subjects (n = 38) and by two subgroups–those with yellow fever virus (YF+, n = 31) or dengue virus exposure (Dengue, n = 11). All data represent mean titers (GMT) ± 95% confidence interval. Statistical significance of the difference between FV-naïve group was assessed by one-way ANOVA with Sidak correction for multiple comparisons. *, <i>P</i> < 0.05, **, <i>P</i> < 0.01, *** <i>P</i>, < 0.001.</p

Adverse events following first and second dose of TV003 in flavivirus-experienced individuals.

<p>Adverse events following first and second dose of TV003 in flavivirus-experienced individuals.</p

Valency of DENV responses after one or two doses of TV003 in subjects who were flavivirus-experienced or -naïve^a prior to vaccination.

<p>Valency of DENV responses after one or two doses of TV003 in subjects who were flavivirus-experienced or -naïve<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005584#t006fn004" target="_blank">^a</a> prior to vaccination.</p

Mean peak neutralizing antibody titers to TV003 in subjects who were flavivirus-experienced or -naïve^a prior to vaccination.

<p>Mean peak neutralizing antibody titers to TV003 in subjects who were flavivirus-experienced or -naïve<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005584#t003fn004" target="_blank">^a</a> prior to vaccination.</p

CONSORT diagram of enrollment and follow up of subjects for first and second dosings of TV003 in subjects who were flavivirus-exposed prior to vaccination with TV003 (Study CIR280).

<p>The schedule of blood draws for serological and virological testing is indicated in the shaded box at right.</p

Frequency of seropositivity to each DENV serotype after one or two doses of TV003 in subjects who were flavivirus-experienced or -naïve^a prior to vaccination.

<p>Frequency of seropositivity to each DENV serotype after one or two doses of TV003 in subjects who were flavivirus-experienced or -naïve<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005584#t005fn005" target="_blank">^a</a> prior to vaccination.</p

Viremia following the first dose of TV003 in flavivirus-experienced subjects (n = 41)^a.

<p>Viremia following the first dose of TV003 in flavivirus-experienced subjects (n = 41)<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005584#t002fn001" target="_blank">^a</a>.</p